Monogram Technologies Inc. - Common Stock (MGRM)

Let's explore the current happenings on the US markets on Tuesday. Below, you'll find the stocks exhibiting unusual volume in today's session.

Monogram gains FDA clearance for its robotic-assisted knee surgery system and plans clinical trials in India to expand applications and market reach.

How Monogram’s (NASDAQ: MGRM) Dynamic Approach To Robotics Could Help Reshape the Future Of Orthopedics

Monogram Orthopedics (NASDAQ: MGRM) Readies Commercialization Of Next-Gen Surgical Robot

Monogram Orthopedics (NASDAQ: MGRM) Lands Key Clinical Trial Partnership With India’s Leading Orthopedic Hospital Group To Advance Its Surgical Robot Tech

MGRM stock results show that Monogram Technologies missed analyst estimates for earnings per share the second quarter of 2024.

MGRM stock results show that Monogram Orthopaedics beat analyst estimates for earnings per share the first quarter of 2024.

Technology Is Enabling Remote Work In More And More Fields – Could Surgery Be Next? Surgical Robot Maker Monogram Orthopedics (NASDAQ: MGRM) Believes So

Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.

U.S. stocks traded lower this morning, with the Dow Jones index falling around 200 points on Friday. Following the market opening Friday, the Dow traded down 0.54% to 38,249.92 while the NASDAQ fell 0.83% to 16,305.21. The S&P 500 also fell, dropping, 0.62% to 5,166.70.

Friday is here and we're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers this morning!

Shares of NextPlat Corp (NASDAQ: NXPL) rose sharply in today’s pre-market trading after the company reported consolidated 2023 revenues of $37.8 million, up 222% year over year

--News Direct--

--News Direct--

Robotic surgeries are going mainstream for a good reason: they make it easier for doctors to perform complex surgeries.